Evidence Note: Evidence strength varies by condition. Chronic pain and epilepsy have the strongest clinical evidence base. Other conditions are treated based on specialist clinical judgement and emerging research. All prescriptions require specialist assessment.
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease affecting an estimated 400,000 people in the United Kingdom. It causes painful, swollen joints — predominantly in the hands, wrists, and feet — and without effective treatment leads to progressive joint damage and disability. While disease-modifying antirheumatic drugs (DMARDs) and biologics have transformed RA management, many patients continue to experience pain, fatigue, and reduced quality of life despite optimal treatment.
Cannabinoids and Inflammation in RA
The endocannabinoid system plays a direct role in immune regulation and inflammation. CB2 receptors are expressed on immune cells including T-cells, B-cells, macrophages, and mast cells — all implicated in RA pathogenesis. CBD specifically has demonstrated immunomodulatory properties, suppressing pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta) in preclinical models. THC provides additional direct analgesic and anti-inflammatory effects at both CB1 and CB2 receptors.
Evidence Supporting Cannabis for RA
A landmark placebo-controlled trial (Blake et al., 2006) of Sativex (THC:CBD oromucosal spray) in RA demonstrated statistically significant improvements in pain on movement, pain at rest, and sleep quality compared to placebo. Real-world UK registries confirm that RA patients treated with cannabis-based medicines report meaningful improvements in pain scores and functional capacity.
How Medical Cannabis Helps RA Patients
Joint pain reduction — both inflammatory and mechanical components
Sleep quality improvement
Morning stiffness reduction
Anxiety and depression associated with chronic disease
Fatigue management
Frequently Asked Questions
Is medical cannabis effective for rheumatoid arthritis pain?
Yes. A 2006 RCT using Sativex (THC:CBD) demonstrated significant reductions in pain on movement, pain at rest, and sleep quality scores in RA patients. Real-world UK registry data further supports patient-reported improvements in pain and function. Cannabis is typically used as an adjunct to, not replacement for, disease-modifying treatment.
Can I get medical cannabis for rheumatoid arthritis in the UK?
Yes. A GMC-registered rheumatologist or specialist cannabis clinician can prescribe cannabis-based medicines for RA where pain remains inadequately controlled despite standard treatment. You can self-refer to a cannabis clinic. The specialist will review your RA history, current DMARDs, and pain levels before determining suitability.
Will medical cannabis interact with my DMARD or biologic medication?
Cannabis-based medicines are generally compatible with most DMARDs (methotrexate, sulfasalazine, hydroxychloroquine) and biologic agents (TNF inhibitors, JAK inhibitors). However, cannabinoids are metabolised via CYP450 enzymes which some medications also use u2014 always disclose your full medication list to your prescribing specialist.
Can medical cannabis reduce RA joint inflammation directly?
Preclinical research shows CBD suppresses pro-inflammatory cytokines (TNF-alpha, IL-6) involved in RA, suggesting potential anti-inflammatory effects beyond simple analgesia. However, clinical trial evidence for direct anti-inflammatory action in humans is still emerging. Current UK prescribing primarily targets pain, sleep, and quality of life rather than disease modification.
Ready to Explore Your Options?
Our GMC-registered specialists assess each patient individually. Book a consultation to discuss whether medical cannabis is appropriate for your condition.
